JP2005519891A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005519891A5 JP2005519891A5 JP2003559435A JP2003559435A JP2005519891A5 JP 2005519891 A5 JP2005519891 A5 JP 2005519891A5 JP 2003559435 A JP2003559435 A JP 2003559435A JP 2003559435 A JP2003559435 A JP 2003559435A JP 2005519891 A5 JP2005519891 A5 JP 2005519891A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- patient
- patients
- syndrome
- respiratory distress
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000028399 Critical Illness Diseases 0.000 claims 2
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims 1
- 102000003973 Fibroblast growth factor 21 Human genes 0.000 claims 1
- 108090000376 Fibroblast growth factor 21 Proteins 0.000 claims 1
- 208000010718 Multiple Organ Failure Diseases 0.000 claims 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 claims 1
- 206010038687 Respiratory distress Diseases 0.000 claims 1
- 206010040047 Sepsis Diseases 0.000 claims 1
- 206010051379 Systemic Inflammatory Response Syndrome Diseases 0.000 claims 1
- 206010069351 acute lung injury Diseases 0.000 claims 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 208000029744 multiple organ dysfunction syndrome Diseases 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34889002P | 2002-01-15 | 2002-01-15 | |
| PCT/US2003/000010 WO2003059270A2 (en) | 2002-01-15 | 2003-01-08 | Method for reducing morbidity and mortality in critically ill patients |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005519891A JP2005519891A (ja) | 2005-07-07 |
| JP2005519891A5 true JP2005519891A5 (https=) | 2006-02-23 |
Family
ID=23370005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003559435A Pending JP2005519891A (ja) | 2002-01-15 | 2003-01-08 | 危篤状態の患者における罹病率および死亡率を低下させる方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20050176631A1 (https=) |
| EP (1) | EP1469880A4 (https=) |
| JP (1) | JP2005519891A (https=) |
| AU (1) | AU2003201810A1 (https=) |
| CA (1) | CA2468610A1 (https=) |
| WO (1) | WO2003059270A2 (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7459540B1 (en) | 1999-09-07 | 2008-12-02 | Amgen Inc. | Fibroblast growth factor-like polypeptides |
| CN1890371A (zh) * | 2003-12-10 | 2007-01-03 | 伊莱利利公司 | 成纤维细胞生长因子的21突变蛋白 |
| WO2006028714A1 (en) * | 2004-09-02 | 2006-03-16 | Eli Lilly And Company | Muteins of fibroblast growth factor 21 |
| EA011390B1 (ru) | 2004-09-02 | 2009-02-27 | Эли Лилли Энд Компани | Мутантные белки (мутеины) фактора роста фибробластов 21 |
| UA95903C2 (ru) | 2005-02-24 | 2011-09-26 | Дифьюжен Фармасьютикалз Ллк | Транс-каротиноиды, их синтез, лекарственная форма и применение |
| CA2682147C (en) | 2007-03-30 | 2017-08-08 | Ambrx, Inc. | Modified fgf-21 polypeptides and their uses |
| EP2296690B1 (en) | 2008-06-04 | 2016-11-30 | Amgen, Inc | Fgf21 mutants and uses thereof |
| JP5878757B2 (ja) | 2008-10-10 | 2016-03-08 | アムジエン・インコーポレーテツド | Ｆｇｆ２１変異体およびその使用 |
| HRP20240135T1 (hr) * | 2009-05-05 | 2024-04-12 | Amgen Inc. | Fgf21 mutanti i njihove upotrebe |
| EP2427207B1 (en) | 2009-05-05 | 2017-08-16 | Amgen, Inc | Fgf21 mutants and uses thereof |
| US8324160B2 (en) * | 2009-06-17 | 2012-12-04 | Amgen Inc. | Chimeric polypeptides and uses thereof |
| KR101875843B1 (ko) | 2009-06-22 | 2018-07-06 | 디퓨젼 파마슈티컬즈 엘엘씨 | 확산 촉진 화합물 및 그 화합물 단독 또는 혈전 용해제와 합쳐진 화합물의 용도 |
| EP2679234A3 (en) * | 2009-12-02 | 2014-04-23 | Amgen Inc. | Binding proteins that bind to human FGFR1C, human beta-klotho and both human FGFR1C and human beta-klotho |
| UA109888C2 (uk) * | 2009-12-07 | 2015-10-26 | ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ | |
| CA2796055A1 (en) | 2010-04-15 | 2011-10-20 | Amgen Inc. | Human fgf receptor and .beta.-klotho binding proteins |
| KR101891357B1 (ko) | 2010-06-02 | 2018-08-24 | 디퓨젼 파마슈티컬즈 엘엘씨 | 양극성 트랜스 카로티노이드의 경구용 제형 |
| JP2014500248A (ja) | 2010-11-05 | 2014-01-09 | コヴェックス・テクノロジーズ・アイルランド・リミテッド | 抗糖尿病化合物 |
| JP6165168B2 (ja) | 2011-12-22 | 2017-07-19 | ファイザー・インク | 抗糖尿病化合物 |
| SMT202100388T1 (it) | 2014-10-24 | 2021-09-14 | Bristol Myers Squibb Co | Polipeptidi fgf-21 modificati e loro usi |
| US11185523B2 (en) | 2016-03-24 | 2021-11-30 | Diffusion Pharmaceuticals Llc | Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer |
| MX2020002206A (es) | 2017-09-08 | 2020-07-20 | Bristol Myers Squibb Co | Factor de crecimiento de fibroblastos 21 (fgf-21) modificado para usarse en metodos para tratar la esteatohepatitis no alcoholica (nash). |
| JP2018135329A (ja) * | 2018-02-19 | 2018-08-30 | ディフュージョン・ファーマシューティカルズ・エルエルシー | 双極性トランスカロテノイド塩及びそれらの使用 |
| CA3104686A1 (en) | 2018-07-03 | 2020-01-09 | Bristol-Myers Squibb Company | Fgf-21 formulations |
| US20220017570A1 (en) | 2018-11-05 | 2022-01-20 | Bristol-Meyers Squibb Company | Method for purifying pegylated protein |
| IL294534A (en) | 2020-01-08 | 2022-09-01 | Bristol Myers Squibb Co | Fgf-21 conjugate formulations |
| JP2023538533A (ja) | 2020-08-07 | 2023-09-08 | ブリストル－マイヤーズ スクイブ カンパニー | 線維症の処置のための、ｃｃｒ２／５拮抗剤と組み合わせたｆｇｆ２１ |
| US20240123031A1 (en) | 2020-11-25 | 2024-04-18 | Bristol-Myers Squibb Company | Methods of treating liver diseases |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6716626B1 (en) * | 1999-11-18 | 2004-04-06 | Chiron Corporation | Human FGF-21 nucleic acids |
| WO2001036640A2 (en) * | 1999-11-18 | 2001-05-25 | Chiron Corporation | Human fgf-21 gene and gene expression products |
| US20020081663A1 (en) * | 2000-01-05 | 2002-06-27 | Conklin Darrell C. | Novel FGF homolog ZFGF11 |
| US20030105302A1 (en) * | 2000-03-08 | 2003-06-05 | Nobuyuki Itoh | Human FGF-23 gene and gene expression products |
| US20020151496A1 (en) * | 2000-12-08 | 2002-10-17 | Bringmann Peter W. | Novel fibroblast growth factors |
| WO2003011213A2 (en) * | 2001-07-30 | 2003-02-13 | Eli Lilly And Company | Method for treating diabetes and obesity |
-
2003
- 2003-01-08 JP JP2003559435A patent/JP2005519891A/ja active Pending
- 2003-01-08 EP EP03700669A patent/EP1469880A4/en not_active Withdrawn
- 2003-01-08 AU AU2003201810A patent/AU2003201810A1/en not_active Abandoned
- 2003-01-08 WO PCT/US2003/000010 patent/WO2003059270A2/en not_active Ceased
- 2003-01-08 US US10/499,608 patent/US20050176631A1/en not_active Abandoned
- 2003-01-08 CA CA002468610A patent/CA2468610A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005519891A5 (https=) | ||
| JP2003526626A5 (https=) | ||
| JP2007514005A5 (https=) | ||
| JP2006503588A5 (https=) | ||
| JP2007523178A5 (https=) | ||
| JP2003503454A5 (https=) | ||
| ES2178943A1 (es) | Uso de compuestos organicos en el tratamiento de enfermedad pulmonar obstructiva cronica. | |
| WO2006059108A3 (en) | ANTI-IL-IRl SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC USES | |
| NO20013988L (no) | Kombinasjoner av formoterol og mometasonfuroat mot astma | |
| JP2003520232A5 (https=) | ||
| JP2006507281A5 (https=) | ||
| CA2733294A1 (en) | Pharmaceutical combination of a tiotropium salt and ciclesonide | |
| JP2012512699A5 (https=) | ||
| JP2004002446A5 (https=) | ||
| TWD104968S1 (zh) | 釣魚用捲線器 | |
| JP2005508963A5 (https=) | ||
| JP2008513510A5 (https=) | ||
| WO2021160192A3 (zh) | 贝壳杉烷类化合物在制备预防和治疗脓毒症及多器官损伤的药物中的应用 | |
| JP2020516689A5 (https=) | ||
| EP2158901A3 (en) | Alpha aztreonam lysinate | |
| JP2007501334A5 (https=) | ||
| WO2002017894A3 (en) | Pharmaceutical formulation of salmeterol and fluticasone propionate | |
| JP2008513426A5 (https=) | ||
| JP2002326936A5 (https=) | ||
| JP2008513427A5 (https=) |